Remission and eular good response in 2125 patients with rheumatoid arthritis (RA) receiving TNF-blocking agents and disease-modifying antirheumatic drugs (Dmards):: Results from a longitudinal observational study.

被引：0

作者：

Kvien, TK

Mikkelsen, K

Nordvåg, BY

Kaufmann, C

Rodevand, E

Schrumpf, M

Mowinckel, P

机构：

[1] Diakonhjemmet Hosp, Oslo, Norway

[2] Lillehammer Hosp Rheumat Dis, Lillehammer, Norway

[3] Univ Hosp No Norway, Tromso, Norway

[4] Buskerud Cent Hosp, Drammen, Norway

[5] St Olav Hosp, Trondheim, Norway

来源：

ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S394 / S394

页数：1

共 50 条

[1] Comparison of remission and EULAR good response rates in 1677 patients with rheumatoid arthritis receiving methotrexate, leflunomide or TNF-blocking agents:: Results from a longitudinal observational study
Kvien, TK
Schrumpf, M
Mowinckel, P
Mikkelsen, K
Nordvág, B
Kaufmann, C
Rodevand, E
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 450 - 450
[2] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
Khoshroo, Ahmadreza
Ramezani, Keyvan
Moghimi, Niusha
Bonakdar, Moein
Ramezani, Nazanin
INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 689 - 697
[3] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
Ahmadreza Khoshroo
Keyvan Ramezani
Niusha Moghimi
Moein Bonakdar
Nazanin Ramezani
Inflammopharmacology, 2023, 31 : 689 - 697
[4] The relative effectiveness of TNF-blocking agents and traditional DMARDS on clinical outcomes:: Results from a longitudinal observational study.
Kvien, TK
Mikkelsen, K
Nordvåg, BY
Kaufmann, C
Rodevand, E
Mowinckel, P
ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S612 - S613
[5] POSTOPERATIVE COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING RITUXIMAB AND CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
Pogozheva, E.
Amirdzhanova, V.
Makarov, S.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 882 - 882
[6] EFFICIENCY OF NON-BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH COMORBIDITY
Mykytenko, G.
Iaremenko, O.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 212 - 213
[7] Effectiveness of TNF-blocking agents compared to traditional DMARD regimens in patients with rheumatoid arthritis (RA) -: A longitudinal observational study
Kvien, TK
Mikkelsen, K
Nordvåg, B
Kaufmann, C
Rldevand, E
Schrumpf, M
Mowinckel, P
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 258 - 259
[8] Priorities for improvement in health in patients with rheumatoid arthritis (RA) who are starting disease-modifying antirheumatic drugs (DMARDs), including biological agents
Heiberg, T
Vinders, M
Olsen, CL
Magnussen, AS
Enersen, TB
Fekete, S
Kvien, TK
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 558 - 558
[9] TNF-blocking agents give larger health benefits in patients with ankylosing spondylitis (AS) than in patients with rheumatoid arthritis (RA):: Results from a longitudinal observational study
Schrumpf, M
Mikkelsen, K
Nordvåg, B
Kaufmann, C
Rldevand, E
Mowinckel, P
Kvien, TK
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 97 - 98
[10] A PROSPECTIVE STUDY OF TAPERING CONVENTIONAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS (C-DMARDS) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN STABLE REMISSION
Romi, Shah
Balakrishnan, Canchi
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 370 - 371

← 1 2 3 4 5 →